GE Healthcare and BAC start collaboration in biopharmaceutical purification
GE Healthcare and BAC BV announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area. Under the terms of the agreement, the two companies plant to develop new affinity chromatography media for human antibodies and adeno-associated virus (AAV) viral vector purification. The first products are expected to be commercially available during 2007 through GE Healthcare's Custom Designed Media business. The collaboration is expected to generate several new innovative affinity chromatography media solutions for biopharmaceutical manufacture and drug discovery research.
Most read news
Organizations
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
![Topic world Antibodies](http://static.chemie.de//media/images/focuspage/022d2694-7e7f-411e-9219-c2cf6ea89d36.png)
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!
![Topic World Chromatography](http://static.chemie.de//media/images/focuspage/b1ed7d61-28a3-45f8-b7fa-4f8970c093c3.jpg)
Topic World Chromatography
Chromatography enables us to separate, identify and thus understand complex substances. Whether in the food industry, pharmaceutical research or environmental analysis - chromatography opens up a treasure trove of information about the composition and quality of our samples. Discover the fascinating world of chromatography!